e/MTIC project InPhoTherm is made possible by our PPS funding. This €2.5 million budget project involves the e/MTIC ecosystem partners TU Eindhoven, Catharina Hospital and Amazec Photonics. The project will be running for 60 months and jointly managed by all partners to ensure an optimum outcome.
About InPhoTherm
Thermodilution is the most widely-used method to measure cardiac output. It involves injecting a known volume of liquid upstream of the heart and then measuring temperature changes downstream. However, one of the disadvantages is its unreliability during routine examinations.
Currently, there is no other widely used method to determine a patient's circulating blood volume status. Knowledge of this volume is essential for a complete understanding of complex cardiovascular and circulatory emergency situations like heart failure.
InPhoTherm is a state-of-the-art project that utilizes integrated photonics to enable non-invasive thermodilution-based analysis. This cutting-edge technology offers early and accurate diagnosis at minimal cost and complexity.
The new technology will first be developed and tested in clinical trials involving healthy volunteers, and later on patients during various medical procedures such as heart surgery, intensive care, cardiology, nephrology, emergency department, general ward, and even at home.
